Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
It promotes mass loss by enhancing energy expenditure, reducing appetite, and improving glucose metabolism, leveraging the complementary actions of GLP-1 and glucagon signaling
This mechanism is unique among current metabolic research compounds
Drug Targets 60 CollinsA
May 2013;79(7):576-9
These codes apply to services from October 1, 2025 through September 30, 2026 under the FY2026 ICD-10-CM release
Although it is mostly converted to nontoxic metabolites by sulfation and glucuronidation, a small amount of the drug is metabolized by cytochrome P450 enzymes (including subtype 2E1) into the toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI)
US$ 28.33
US$ 27.56
US$ 28.52
